Document is current
Any future updates will be listed below
-
Authors
Kawabata, Emily
Major-Smith, Daniel
Clayton, Gemma L.
Shapland, Chin Yang
Morris, Tim P.
Carter, Alice R.
Fernández-Sanlés, Alba
Borges, Maria Carolina
Tilling, Kate
Griffith, Gareth J.
Millard, Louise A. C.
Smith, George Davey
Lawlor, Deborah A.
Hughes, Rachael A.
- License Information
-
More Information
Article History
Received: 24 March 2024
Accepted: 21 October 2024
First Online: 13 November 2024
Declarations
:
: For the simulation study, data were completely simulated, which did not require approval from an ethics committee or consent from participants. UKB received ethical approval from the UK National Health Service’s National Research Ethics Service (ref. 11/NW/0382). All participants provided written and informed consent for data collection, analysis, and record linkage. This research was conducted under UKB application number 16729.
: Not applicable.
: TPM has received consultancy fees from: Bayer Healthcare Pharmaceuticals, Alliance Pharmaceuticals, Gilead Sciences, and Kite Pharmaceuticals. Since January 2023, ARC has been an employee of Novo Nordisk Research Centre Oxford, which is not related to the current work and had no involvement in the decision to publish. The remaining authors declare that they have no competing interests.
